Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "Pharmacologic Substance[C1909]|Biological Agent[C307]|Antineoplastic Biological Agent" in comments (approximate match)

Showing 41 - 50 of 183 results

First page
Previous page
Next page
Next page

CANTUZUMAB RAVTANSINE

RNQ8JQ4R9P

Subunit 1 (449) Similarity Search Subunit 2 (449) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Sequence Search

Subunit 1 (449) Similarity Search Subunit 2 (449) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Status:

Investigational

Source:

INN:cantuzumab ravtansine [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/RNQ8JQ4R9P

Class:

PROTEIN

APRUTUMAB IXADOTIN

DDD2AB5TWK

Subunit 1 (451) Similarity Search Subunit 2 (451) Similarity Search Subunit 3 (216) Similarity Search Subunit 4 (216) Similarity Search

Sequence Search

Subunit 1 (451) Similarity Search Subunit 2 (451) Similarity Search Subunit 3 (216) Similarity Search Subunit 4 (216) Similarity Search

Status:

Investigational

Source:

NCT02368951: Phase 1 Interventional Terminated Medical Oncology

(2015)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02368951

Class:

PROTEIN

TOVETUMAB

2XY62K75UV

Subunit 1 (446) Similarity Search Subunit 2 (446) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search

Sequence Search

Subunit 1 (446) Similarity Search Subunit 2 (446) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search

Status:

Investigational

Source:

NCT01268566: Phase 2 Interventional Completed Glioblastoma Multiforme

(2011)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01268566

Class:

PROTEIN

NARNATUMAB

R42YK40U9M

Subunit 1 (452) Similarity Search Subunit 2 (452) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (452) Similarity Search Subunit 2 (452) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

NCT01119456: Phase 1 Interventional Completed Cancer

(2010)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01119456

Class:

PROTEIN

ETARACIZUMAB

41W9MFI160

Subunit 1 (447) Similarity Search Subunit 2 (447) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (447) Similarity Search Subunit 2 (447) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

NCT00072930: Phase 2 Interventional Completed Prostate Cancer

(2003)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00072930

Class:

PROTEIN

FLANVOTUMAB

ZNV4738BS6

Subunit 1 (449) Similarity Search Subunit 2 (449) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search

Sequence Search

Subunit 1 (449) Similarity Search Subunit 2 (449) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search

Status:

Investigational

Source:

NCT01137006: Phase 1 Interventional Completed Malignant Melanoma

(2010)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01137006

Class:

PROTEIN

SIBROTUZUMAB

552U6E1NIW

Sequence Search

Status:

Investigational

Source:

INN:sibrotuzumab

Source URL:

https://tripod.nih.gov/npc/#Download

Class:

PROTEIN

Lipustobart

H6KN31H3XF

Subunit 1 (447) Similarity Search Subunit 2 (447) Similarity Search Subunit 3 (218) Similarity Search Subunit 4 (218) Similarity Search

Sequence Search

Subunit 1 (447) Similarity Search Subunit 2 (447) Similarity Search Subunit 3 (218) Similarity Search Subunit 4 (218) Similarity Search

Status:

Investigational

Source:

INN:lipustobart [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/H6KN31H3XF

Class:

PROTEIN

BUDIGALIMAB

6VDO4TY3OO

Subunit 1 (448) Similarity Search Subunit 2 (448) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Sequence Search

Subunit 1 (448) Similarity Search Subunit 2 (448) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Status:

Investigational

Source:

NCT04306900: Phase 1 Interventional Completed Solid Tumor, Adult

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04306900

Class:

PROTEIN

PEPINEMAB

BPZ4A29SYE

Subunit 1 (445) Similarity Search Subunit 2 (445) Similarity Search Subunit 3 (218) Similarity Search Subunit 4 (218) Similarity Search

Sequence Search

Subunit 1 (445) Similarity Search Subunit 2 (445) Similarity Search Subunit 3 (218) Similarity Search Subunit 4 (218) Similarity Search

Status:

Investigational

Source:

NCT02481674: Phase 2 Interventional Completed Huntington's Disease

(2015)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02481674

Class:

PROTEIN

Protein

CANTUZUMAB RAVTANSINE

Protein

APRUTUMAB IXADOTIN

Protein

Protein

Protein

Protein

Protein

Protein

Protein

Protein

Showing 41 - 50 of 183 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1